Form 8-K - Current report:
SEC Accession No. 0001193125-24-262940
Filing Date
2024-11-21
Accepted
2024-11-21 06:06:02
Documents
16
Period of Report
2024-11-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d832756d8k.htm   iXBRL 8-K 24993
2 EX-99.1 d832756dex991.htm EX-99.1 38990
6 GRAPHIC g832756dsp4.jpg GRAPHIC 10118
7 GRAPHIC g832756g1121070300398.jpg GRAPHIC 6980
  Complete submission text file 0001193125-24-262940.txt   224613

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20241120.xsd EX-101.SCH 2518
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20241120_lab.xml EX-101.LAB 18540
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20241120_pre.xml EX-101.PRE 11632
19 EXTRACTED XBRL INSTANCE DOCUMENT d832756d8k_htm.xml XML 3881
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 241482049
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)